Antineoplaston Therapy in Treating Patients With Multiple Myeloma

Summary

Current therapies for Multiple Myeloma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Multiple Myeloma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Multiple Myeloma.

Timeline

Start

1996-04-04

Primary completion

1999-10-21

Completion

1999-10-21

Drugs

Indications